Onivyde liposomal pégylé 4.3 mg/ml, dispersion à diluer pour perfusion - Swissmedic Key 65994003 PP Registration Holder Servier (Suisse) SA Name Onivyde liposomal pégylé 4.3 mg/ml, dispersion à diluer pour perfusion Date of registration 25.07.2017 Introduction of Sequence 25.07.2017 ATC-Classification Irinotecan (L01CE02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) Show package size Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Deductible k.A. Feedback FB GTIN 7680659940037 Medication Code Synthetika Pharmacode Disponibility
Composition irinotecanum 43 mg ut irinotecani sucrosofas corresp. irinotecani hydrochloridum trihydricum 50 mg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, acidum hydroxyethylpiperazinethansulfonicum, natrii chloridum corresp. natrium 33.1 mg, aqua ad iniectabile q.s. ad solutionem pro 10 ml. Packungsbestandteile Galenic Form dispersion à diluer pour perfusion Excipiens Active Agent Dose Irinotecan 43mg / 10ml
Inactive agents 1,2-distearoyl-Sn-Glycero-3-Phosphocholinum Acidum Hydroxyethylpiperazinethansulfonicum Cholesterol N-(carbonyl-Methoxypolyethylenglycoli 2000)-1,2-distearoyl-Sn-Glycero-3-Phosphoethanolaminum Natricum Sodium Chloride
Source Data was imported : 17.12.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
